Accès ouvert
2026
preprint
OpenAlex
Frances C. Wilson, Derek J. Zangerle, Lincoln E. Rozen, Jessica J. Fliess et autres
Abstract Background Wide-spread mast cell (MC)-associated symptoms and MC activation syndrome (MCAS) are often reported in patients with hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD). The goal of this study was to develop a novel MC score based on 11 …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Frances C. Wilson, Derek J. Zangerle, Ashley A. Darakjian, Mira Bhutani et autres
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Faisal Fa’ak, Maryam Buni, Adewunmi Falohun, Huifang Lu et autres
BACKGROUND: Management of immune-related adverse events (irAEs) is important as they cause treatment interruption or discontinuation, more often seen with combination immune checkpoint inhibitor (ICI) therapy. Here, we retrospectively evaluated the safety and effectiveness of anti-interleukin-6 receptor (anti-IL-6R) as therapy for irAEs. …
us, Égypte
(code pays fourni par la source)
Accès ouvert
2021
conference-abstract
OpenAlex
Faisal Fa’ak, Chrystia M. Zobniw, Maryam Buni, L Lu et autres
Background Managing immune-related adverse events (irAEs) has become a critical challenge with the increasing implementation of immune-checkpoint inhibitors (ICIs) in cancer treatment. IrAEs may cause treatment interruption or discontinuation, the rate of which is higher with multi-agent ICI regimen needed to overcome …
us
(code pays fourni par la source)